SelectQuote, Inc. (NYSE:SLQT) exceeded analyst expectations in its fourth-quarter fiscal 2025 results, reporting revenue of $345.1 million, up 12.3% year-over-year, versus the consensus forecast of $343.94 million. The company posted a quarterly loss of just $0.02 per share, far better than the predicted -$0.16 per share.
Following the earnings release, SelectQuote shares rose 1.09% in pre-market trading.
The company’s growth was driven largely by its Healthcare Services segment, which surged 47% YoY to $214 million, while its pharmacy unit, SelectRx, grew its membership 31% to 108,018. Consolidated revenue for Q4 increased from $307.2 million a year ago.
“The strength of our holistic healthcare services model was broadly exhibited in fiscal 2025, and we firmly believe the years ahead will increasingly drive substantial value for each of our stakeholders,” said Tim Danker, SelectQuote Chief Executive Officer. “We are proud to have delivered financial results well in excess of our initial expectations for the 3rd consecutive year.”
Looking ahead, SelectQuote provided an optimistic FY26 outlook, forecasting revenue between $1.65 billion and $1.75 billion, well above the analyst consensus of $1.52 billion. The midpoint implies roughly 11.5% growth over fiscal 2025.
Performance across segments was mixed: the Senior segment saw revenue decline 28% YoY to $82.5 million, with approved Medicare Advantage policies down 20% to 85,344, while the Life segment rose 14% to $48 million.
The company ended the quarter with $35.7 million in cash and equivalents, compared with $42.7 million at the close of fiscal 2024.
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.